加州再生医学研究所独立公民监督委员会定期会议治理小组委员会。 根据加利福尼亚州干细胞研究与治疗法案组织。 将最新的 CIRM 新闻、即将召开的会议的信息以及资金机会发送到您的收件箱。

Objetivo de la investigación Se combinará un injerto de pasta articular que contiene células madre mesenquimales y un hidrogel adhesivo que favorece el crecimiento del cartílago para lograr un ...

The maximum total funding for a DISC4 Award is $13 million per award. The maximum award duration is four years. Applicant Core Teams must be multi-institutional and include at least five California ...

Prior to this study, glial cell-based therapies have never been tested as a therapeutic candidate for the treatment of mild traumatic brain injury . Milestone 1- Determine hiPSC-GEPs efficacy ...

这项工作确定了转录因子 Mef2C 在血液系统中的新作用。 我们发现 Mef2c 在调节血小板生成和保护免疫细胞免于过早衰老方面具有双重作用。 科学摘要： 基本螺旋-环-螺旋转录因子干细胞白血病基因 (Scl) 是造血的主要调节因子，对于造血规范以及红系和巨核细胞 ...

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.

Colin M McCrimmon, Daniel Toker, Marie Pahos, Kevin Lozano, Jack J Lin, Jack Parent, Andrew Tidball, Jie Zheng, Laszlo Molnar, Istvan Mody, Bennett G Novitch, Ranmal A Samarasinghe Neurodevelopmental ...

从人类胚胎干细胞产生功能性胰腺β细胞或肝细胞的潜力为分别治疗糖尿病和慢性肝病的细胞替代疗法提供了一条有前途的途径。尽管取得了进展，但由干细胞产生的β细胞和肝细胞仍然缺乏正常人类β细胞或肝细胞的许多特征。胰腺和肝脏由共同的前体细胞产生 ...

The therapeutic candidate we aim to discover under this award is clomipramine, an antidepressant that might help reduce a harmful protein in the nerve cells of patients with CMT1A disease. The ...

beta-globin lentiviral vectors (beta-LV) have faced challenges in clinical translation for gene therapy of sickle cell disease (SCD) due to low titer and sub-optimal gene transfer to hematopoietic ...